Tumor lactic acid: a potential target for cancer therapy.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 2, p. 90, doi. 10.1007/s12272-023-01431-8
- By:
- Publication type:
- Article
Works matching IS 02536269 AND DT 2023 AND VI 46 AND IP 2
Results: 5
1
2
Dapagliflozin attenuates myocardial remodeling in hypertension by activating the circadian rhythm signaling pathway.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 2, p. 117, doi. 10.1007/s12272-023-01430-9
- By:
- Publication type:
- Article
3
Innate immune sensing of pathogens and its post-transcriptional regulations by RNA-binding proteins.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 2, p. 65, doi. 10.1007/s12272-023-01429-2
- By:
- Publication type:
- Article
4
Distinctive role of inflammation in tissue repair and regeneration.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 2, p. 78, doi. 10.1007/s12272-023-01428-3
- By:
- Publication type:
- Article
5
Effects of CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy subjects.
- Published in:
- Archives of Pharmacal Research, 2023, v. 46, n. 2, p. 111, doi. 10.1007/s12272-022-01423-0
- By:
- Publication type:
- Article